16 posts
Early screening is key, according to a Alzheimer's Association public health expert. The blood biomarker screening for Alzheimer's may have benefits, so speak with your doctor if the test is the right option for you.
A blood biomarker test for Alzheimer’s disease was approved by the Food and Drug Administration well over a year ago, in May 2025, but according to medical professionals and advocacy organizations like the Alzheimer’s Association, there is still a significant public knowledge gap.
Climate Change and Resiliency-focused articles and Q&As are coming soon.
Originally from Brooklyn, Barbara Weiss, 70, lives on Long Island, N.Y., with Dennis, 73, her husband of nearly 50 years, who received a diagnosis of mild cognitive impairment in 2023 and early-stage Alzheimer’s disease in 2026.
Alex Miller, 40, temporarily relocated to Alabama, where he was a primary caregiver for his father who was aging in place with dementia, glaucoma and other health issues. Today, Miller talks with his father every week, but wishes he could do more.
Kelly Glover is a co-caregiver with other relatives for her father who is aging in place with Alzheimer’s disease in N.J. Glover is a Congressional Team ACT Member, part of the Alzheimer’s Impact Movement (AIM), the sister organization of the Alzheimer’s Association.
Health Nation News is a new independent local health and science media news source for New York metro area residents.
